vs
Golden Matrix Group, Inc.（GMGI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Golden Matrix Group, Inc.的1.5倍（$75.5M vs $49.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -15.8%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $6.4M），过去两年Golden Matrix Group, Inc.的营收复合增速更高（104.6% vs 31.3%）
Golden Matrix Group Inc.是一家全球化游戏科技企业，开发并授权专属线上游戏平台、社交棋牌产品及互动游戏解决方案，服务覆盖北美、欧洲、亚太地区的B2B客户，同时运营面向普通用户的休闲游戏产品。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GMGI vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$49.6M
营收增速更快
PBYI
高出43.5%
-15.8%
自由现金流更多
PBYI
多$7.9M
$6.4M
两年增速更快
GMGI
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.6M | $75.5M |
| 净利润 | $-88.7M | — |
| 毛利率 | 57.5% | 69.3% |
| 营业利润率 | -188.3% | 22.7% |
| 净利率 | -179.0% | — |
| 营收同比 | -15.8% | 27.7% |
| 净利润同比 | -4880.1% | — |
| 每股收益（稀释后） | $-7.73 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMGIPBYI
| Q4 25 | $49.6M | $75.5M | ||
| Q3 25 | $47.3M | $54.5M | ||
| Q2 25 | $43.2M | $52.4M | ||
| Q1 25 | $42.7M | $46.0M | ||
| Q4 24 | $58.9M | $59.1M | ||
| Q3 24 | $41.0M | $80.5M | ||
| Q2 24 | $39.4M | $47.1M | ||
| Q1 24 | $11.8M | $43.8M |
净利润GMGIPBYI
| Q4 25 | $-88.7M | — | ||
| Q3 25 | $566.0K | $8.8M | ||
| Q2 25 | $-3.6M | $5.9M | ||
| Q1 25 | $-231.6K | $3.0M | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $-3.4M | $20.3M | ||
| Q2 24 | $64.9K | $-4.5M | ||
| Q1 24 | $74.5K | $-4.8M |
毛利率GMGIPBYI
| Q4 25 | 57.5% | 69.3% | ||
| Q3 25 | 55.8% | 77.7% | ||
| Q2 25 | 56.4% | 76.5% | ||
| Q1 25 | 56.6% | 77.1% | ||
| Q4 24 | 69.8% | 76.4% | ||
| Q3 24 | 54.7% | 63.9% | ||
| Q2 24 | 55.0% | 77.4% | ||
| Q1 24 | 28.5% | 75.5% |
营业利润率GMGIPBYI
| Q4 25 | -188.3% | 22.7% | ||
| Q3 25 | -0.8% | 17.6% | ||
| Q2 25 | -5.3% | 12.7% | ||
| Q1 25 | -0.2% | 8.7% | ||
| Q4 24 | 5.6% | 22.6% | ||
| Q3 24 | -2.4% | 27.4% | ||
| Q2 24 | 0.3% | -4.6% | ||
| Q1 24 | 2.4% | -5.3% |
净利率GMGIPBYI
| Q4 25 | -179.0% | — | ||
| Q3 25 | 1.2% | 16.2% | ||
| Q2 25 | -8.3% | 11.2% | ||
| Q1 25 | -0.5% | 6.5% | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | -8.3% | 25.2% | ||
| Q2 24 | 0.2% | -9.6% | ||
| Q1 24 | 0.6% | -11.0% |
每股收益（稀释后）GMGIPBYI
| Q4 25 | $-7.73 | $0.26 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $-0.13 | $0.40 | ||
| Q3 24 | $-0.03 | $0.41 | ||
| Q2 24 | $0.00 | $-0.09 | ||
| Q1 24 | $0.00 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $46.5M | $130.3M |
| 总资产 | $118.1M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GMGIPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务GMGIPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GMGIPBYI
| Q4 25 | $46.5M | $130.3M | ||
| Q3 25 | $123.5M | $115.3M | ||
| Q2 25 | $121.3M | $104.7M | ||
| Q1 25 | $108.5M | $97.1M | ||
| Q4 24 | $105.1M | $92.1M | ||
| Q3 24 | $94.3M | $71.1M | ||
| Q2 24 | $90.4M | $48.5M | ||
| Q1 24 | $32.1M | $51.0M |
总资产GMGIPBYI
| Q4 25 | $118.1M | $216.3M | ||
| Q3 25 | $209.8M | $202.9M | ||
| Q2 25 | $210.3M | $194.9M | ||
| Q1 25 | $214.0M | $196.2M | ||
| Q4 24 | $213.7M | $213.3M | ||
| Q3 24 | $213.5M | $220.7M | ||
| Q2 24 | $191.5M | $205.0M | ||
| Q1 24 | $37.1M | $214.1M |
负债/权益比GMGIPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $6.4M | $14.4M |
| 自由现金流率自由现金流/营收 | 13.0% | 19.1% |
| 资本支出强度资本支出/营收 | 3.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $19.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流GMGIPBYI
| Q4 25 | $8.2M | $14.4M | ||
| Q3 25 | $7.0M | $9.7M | ||
| Q2 25 | $2.4M | $14.1M | ||
| Q1 25 | $7.7M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $4.8M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | $8.2K | $11.2M |
自由现金流GMGIPBYI
| Q4 25 | $6.4M | $14.4M | ||
| Q3 25 | $6.2M | $9.7M | ||
| Q2 25 | $-89.4K | $14.1M | ||
| Q1 25 | $6.6M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $2.3M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | $6.7K | — |
自由现金流率GMGIPBYI
| Q4 25 | 13.0% | 19.1% | ||
| Q3 25 | 13.1% | 17.7% | ||
| Q2 25 | -0.2% | 26.8% | ||
| Q1 25 | 15.5% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | 5.6% | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | 0.1% | — |
资本支出强度GMGIPBYI
| Q4 25 | 3.6% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 5.7% | 0.0% | ||
| Q1 25 | 2.6% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 6.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率GMGIPBYI
| Q4 25 | — | — | ||
| Q3 25 | 12.42× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
PBYI
暂无分部数据
